STMN1 and esophageal squamous cell carcinoma: The results showed that the level of serum stathmin in ESCC patients was significantly higher than that in healthy controls (5.98±2.89 ng/ml vs. 2.16±1.19 ng/ml, P < 0.001), which indicated that high levels of stathmin may be particularly related to the malignant behavior of ESCC.